Watchlist Manager

Watchlist

Price: 20.09 CNY -0.64% Market Closed

Market Cap: ¥3B

	ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd SSE:603976	CN
F	First Helium Inc XTSX:HELI	CA
	AdvancedAdvT Ltd LSE:ADVT	UK
G	Gubra A/S CSE:GUBRA	DK
K	Kaushalya Infrastructure Development Corporation Ltd BSE:532925	IN
B	Bonia Corporation Bhd KLSE:BONIA	MY
	Esenboga Elektrik Uretim AS IST:ESEN.E	TR
A	Audix Corp TWSE:2459	TW
	A&D Holon Holdings Co Ltd TSE:7745	JP
	Studio Alice Co Ltd TSE:2305	JP
A	Aeroflex Industries Ltd NSE:AEROFLEX	IN
	Fanhua Inc NASDAQ:FANH	CN
	Gimv NV LSE:0EKR	BE
	Banco do Estado de Sergipe SA BOVESPA:BGIP3	BR
A	Arcplus Group PLC SSE:600629	CN
	Arteria Networks Corp TSE:4423	JP

Income Statement

Currency: CNY

	Jun-2017	Sep-2017	Dec-2017	Mar-2018	Jun-2018	Sep-2018	Dec-2018	Mar-2019	Jun-2019	Sep-2019	Dec-2019	Mar-2020	Jun-2020	Sep-2020	Dec-2020	Mar-2021	Jun-2021	Sep-2021	Dec-2021	Mar-2022	Jun-2022	Sep-2022	Dec-2022	Mar-2023	Jun-2023	Sep-2023	Dec-2023	Mar-2024	Jun-2024	Sep-2024	Dec-2024	Mar-2025	Jun-2025	Sep-2025
Revenue
Interest Expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	3	8	13	18	20	19	20	20	21	21	21	21	21	21	21	21	0	0
Revenue	503 N/A	501 0%	509 +2%	532 +5%	563 +6%	581 +3%	596 +3%	606 +2%	549 -9%	527 -4%	521 -1%	499 -4%	509 +2%	487 -4%	502 +3%	513 +2%	570 +11%	701 +23%	797 +14%	866 +9%	883 +2%	835 -5%	796 -5%	797 +0%	833 +5%	874 +5%	901 +3%	921 +2%	914 -1%	842 -8%	801 -5%	717 -11%	664 -7%	649 -2%
Gross Profit
Cost of Revenue	(358)	(356)	(348)	(376)	(404)	(420)	(425)	(443)	(397)	(383)	(380)	(374)	(389)	(375)	(375)	(389)	(430)	(517)	(598)	(659)	(679)	(662)	(643)	(651)	(691)	(740)	(759)	(777)	(761)	(685)	(654)	(579)	(545)	(545)
Gross Profit	144 N/A	145 +1%	161 +11%	156 -3%	159 +2%	161 +1%	171 +6%	164 -4%	152 -7%	144 -5%	141 -2%	125 -11%	120 -4%	113 -6%	127 +13%	124 -3%	140 +13%	184 +32%	198 +8%	207 +4%	204 -1%	173 -15%	153 -11%	146 -5%	143 -2%	133 -6%	142 +6%	144 +2%	152 +6%	157 +3%	147 -6%	138 -6%	119 -14%	105 -12%
Operating Income
Operating Expenses	(62)	(61)	(66)	(56)	(60)	(65)	(90)	(82)	(88)	(84)	(82)	(71)	(58)	(61)	(76)	(73)	(81)	(97)	(75)	(75)	(74)	(73)	(82)	(84)	(83)	(69)	(86)	(80)	(80)	(81)	(71)	(75)	(78)	(71)
Selling, General & Administrative	(61)	(63)	(70)	(66)	(69)	(71)	(83)	(76)	(73)	(72)	(74)	(71)	(69)	(67)	(67)	(69)	(76)	(88)	(60)	(61)	(52)	(42)	(57)	(57)	(62)	(59)	(59)	(61)	(60)	(60)	(58)	(52)	(54)	(51)
Research & Development	0	0	0	0	0	0	(3)	(4)	(13)	(15)	(5)	(13)	(6)	(6)	(7)	(9)	(10)	(13)	(11)	(15)	(19)	(28)	(15)	(26)	(24)	(16)	(17)	(26)	(25)	(24)	(16)	(17)	(15)	(14)
Depreciation & Amortization	0	0	(4)	0	0	0	(5)	0	0	0	(8)	0	0	0	(9)	0	0	0	(11)	0	0	0	(15)	0	0	0	(16)	0	0	0	(14)	0	0	0
Other Operating Expenses	(1)	3	8	10	9	6	1	(2)	(1)	3	4	14	17	13	7	5	5	5	7	1	(4)	(4)	5	(2)	4	6	6	8	5	3	16	(6)	(9)	(7)
Operating Income	83 N/A	85 +3%	95 +12%	100 +5%	99 0%	96 -4%	81 -15%	82 +1%	65 -21%	60 -8%	59 -2%	54 -8%	62 +15%	52 -16%	51 -2%	50 -2%	59 +17%	88 +49%	123 +40%	132 +7%	129 -2%	100 -23%	71 -29%	62 -13%	60 -3%	65 +8%	56 -14%	65 +16%	73 +13%	76 +4%	76 0%	63 -17%	41 -35%	34 -19%
Pre-Tax Income
Interest Income Expense	0	1	2	3	9	12	13	15	13	12	13	12	12	12	11	10	6	4	2	1	(4)	(8)	(12)	(16)	(12)	(13)	(11)	(11)	(11)	(11)	(11)	(11)	(12)	(12)
Non-Reccuring Items	0	0	(0)	0	0	(0)	0	0	0	0	0	0	0	0	0	0	0	0	(2)	0	0	0	(0)	0	0	0	(0)	0	0	0	0	0	0	0
Gain/Loss on Disposition of Assets	(1)	0	(0)	0	0	0	(0)	0	0	0	(1)	0	0	0	(1)	0	0	0	(1)	0	0	0	(1)	0	0	0	(0)	0	0	0	(5)	0	0	0
Total Other Income	4	4	1	(5)	(5)	(5)	0	0	(0)	(1)	0	(1)	(0)	(0)	0	2	2	3	4	0	1	0	1	(0)	(1)	(1)	0	(1)	(1)	(2)	0	(4)	(4)	(3)
Pre-Tax Income	87 N/A	89 +2%	97 +9%	97 +0%	103 +5%	102 -1%	94 -7%	97 +3%	78 -20%	72 -8%	71 0%	66 -7%	74 +12%	64 -14%	61 -4%	63 +2%	66 +6%	94 +42%	126 +33%	132 +5%	126 -5%	92 -27%	59 -36%	45 -23%	47 +4%	51 +9%	45 -12%	52 +17%	61 +16%	64 +5%	60 -5%	48 -20%	25 -48%	19 -26%
Net Income
Tax Provision	(12)	(11)	(15)	(15)	(16)	(17)	(11)	(12)	(10)	(8)	(10)	(10)	(10)	(9)	(8)	(9)	(9)	(14)	(19)	(20)	(18)	(12)	6	7	8	7	(5)	(4)	(7)	(7)	(7)	(5)	(2)	(1)
Income from Continuing Operations	75	77	82	82	87	84	83	85	68	63	61	57	64	55	53	54	57	81	107	113	108	80	65	52	55	58	40	48	54	56	53	43	23	18
Net Income (Common)	75 N/A	77 +4%	82 +6%	82 +0%	87 +5%	84 -3%	83 -2%	85 +3%	68 -21%	63 -6%	61 -3%	57 -7%	64 +13%	55 -14%	53 -4%	54 +2%	57 +6%	81 +42%	107 +32%	113 +6%	108 -4%	80 -26%	65 -19%	52 -20%	55 +6%	58 +6%	40 -31%	48 +20%	54 +12%	56 +4%	53 -6%	43 -19%	23 -47%	18 -23%
EPS (Diluted)	0.65 N/A	0.51 -22%	0.65 +27%	0.54 -17%	0.57 +6%	0.55 -4%	0.55 N/A	0.56 +2%	0.45 -20%	0.42 -7%	0.4 -5%	0.38 -5%	0.43 +13%	0.37 -14%	0.35 -5%	0.36 +3%	0.38 +6%	0.53 +39%	0.71 +34%	0.75 +6%	0.72 -4%	0.38 -47%	0.43 +13%	0.34 -21%	0.36 +6%	0.39 +8%	0.27 -31%	0.32 +19%	0.36 +12%	0.37 +3%	0.35 -5%	0.28 -20%	0.15 -46%	0.12 -20%

Income Statement Balance Sheet Cash Flow Statement

ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd
SSE:603976

Income Statement

Earnings Waterfall
ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd

Income Statement
ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd

See Also

Company

Help

Tools

Stocks

ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd SSE:603976

Income Statement

Earnings Waterfall ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd

Income Statement ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd

See Also

Company

Help

Tools

Stocks

ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd
SSE:603976

Earnings Waterfall
ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd

Income Statement
ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd